The global Chronic Myeloid Leukemia Treatment Drugs market was valued at US$ 718 million in 2023 and is anticipated to reach US$ 944.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Chronic Myeloid Leukemia Treatment Drugs Market

Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Myeloid Leukemia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Myeloid Leukemia Treatment Drugs.

Report Scope

The Chronic Myeloid Leukemia Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Myeloid Leukemia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Myeloid Leukemia Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Myeloid Leukemia Treatment Drugs Market Report

Report Metric	Details
Report Name	Chronic Myeloid Leukemia Treatment Drugs Market
Accounted market size in 2023	US$ 718 million
Forecasted market size in 2030	US$ 944.9 million
CAGR	4.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tablet Solution Capsule
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.), Lupin, IL-YANG PHARM CO. LTD., Million Health Pharmaceuticals, Celon Labs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Myeloid Leukemia Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Myeloid Leukemia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Chronic Myeloid Leukemia Treatment Drugs Market growing?

Ans: The Chronic Myeloid Leukemia Treatment Drugs Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Chronic Myeloid Leukemia Treatment Drugs Market size in 2030?

Ans: The Chronic Myeloid Leukemia Treatment Drugs Market size in 2030 will be US$ 944.9 million.

Who are the main players in the Chronic Myeloid Leukemia Treatment Drugs Market report?

Ans: The main players in the Chronic Myeloid Leukemia Treatment Drugs Market are Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.), Lupin, IL-YANG PHARM CO. LTD., Million Health Pharmaceuticals, Celon Labs

What are the Application segmentation covered in the Chronic Myeloid Leukemia Treatment Drugs Market report?

Ans: The Applications covered in the Chronic Myeloid Leukemia Treatment Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Chronic Myeloid Leukemia Treatment Drugs Market report?

Ans: The Types covered in the Chronic Myeloid Leukemia Treatment Drugs Market report are Tablet, Solution, Capsule

1 Chronic Myeloid Leukemia Treatment Drugs Market Overview

1.1 Product Overview and Scope of Chronic Myeloid Leukemia Treatment Drugs

1.2 Chronic Myeloid Leukemia Treatment Drugs Segment by Type

1.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Tablet

1.2.3 Solution

1.2.4 Capsule

1.3 Chronic Myeloid Leukemia Treatment Drugs Segment by Application

1.3.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Estimates and Forecasts

1.4.1 Global Chronic Myeloid Leukemia Treatment Drugs Revenue 2019-2030

1.4.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales 2019-2030

1.4.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Chronic Myeloid Leukemia Treatment Drugs Market Competition by Manufacturers

2.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Chronic Myeloid Leukemia Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs, Product Type & Application

2.7 Chronic Myeloid Leukemia Treatment Drugs Market Competitive Situation and Trends

2.7.1 Chronic Myeloid Leukemia Treatment Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Chronic Myeloid Leukemia Treatment Drugs Players Market Share by Revenue

2.7.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Chronic Myeloid Leukemia Treatment Drugs Retrospective Market Scenario by Region

3.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Chronic Myeloid Leukemia Treatment Drugs Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region: 2019-2030

3.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region: 2019-2024

3.2.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region: 2025-2030

3.3 Global Chronic Myeloid Leukemia Treatment Drugs Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Region: 2019-2030

3.3.1 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Region: 2019-2024

3.3.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Region: 2025-2030

3.4 North America Chronic Myeloid Leukemia Treatment Drugs Market Facts & Figures by Country

3.4.1 North America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2030)

3.4.3 North America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Chronic Myeloid Leukemia Treatment Drugs Market Facts & Figures by Country

3.5.1 Europe Chronic Myeloid Leukemia Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2030)

3.5.3 Europe Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Chronic Myeloid Leukemia Treatment Drugs Market Facts & Figures by Country

3.7.1 Latin America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2030)

3.7.3 Latin America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Type (2019-2030)

4.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Type (2019-2024)

4.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Type (2025-2030)

4.1.3 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2030)

4.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Type (2019-2030)

4.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Type (2019-2024)

4.2.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Type (2025-2030)

4.2.3 Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Chronic Myeloid Leukemia Treatment Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2030)

5.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2024)

5.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2025-2030)

5.1.3 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2030)

5.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Application (2019-2030)

5.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Application (2019-2024)

5.2.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Application (2025-2030)

5.2.3 Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Chronic Myeloid Leukemia Treatment Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva Pharmaceutical Industries Ltd

6.1.1 Teva Pharmaceutical Industries Ltd Corporation Information

6.1.2 Teva Pharmaceutical Industries Ltd Description and Business Overview

6.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.2 F. Hoffmann-La Roche Ltd.

6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information

6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview

6.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Corporation Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Bristol-Myers Squibb Company

6.4.1 Bristol-Myers Squibb Company Corporation Information

6.4.2 Bristol-Myers Squibb Company Description and Business Overview

6.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates

6.5 Pfizer Inc.

6.5.1 Pfizer Inc. Corporation Information

6.5.2 Pfizer Inc. Description and Business Overview

6.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.5.5 Pfizer Inc. Recent Developments/Updates

6.6 Takeda Pharmaceutical Company Limited

6.6.1 Takeda Pharmaceutical Company Limited Corporation Information

6.6.2 Takeda Pharmaceutical Company Limited Description and Business Overview

6.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.6.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates

6.7 Innovent Biologics, Inc.

6.6.1 Innovent Biologics, Inc. Corporation Information

6.6.2 Innovent Biologics, Inc. Description and Business Overview

6.6.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.7.5 Innovent Biologics, Inc. Recent Developments/Updates

6.8 Viatris Inc. (Mylan N.V.)

6.8.1 Viatris Inc. (Mylan N.V.) Corporation Information

6.8.2 Viatris Inc. (Mylan N.V.) Description and Business Overview

6.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.8.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates

6.9 Lupin

6.9.1 Lupin Corporation Information

6.9.2 Lupin Description and Business Overview

6.9.3 Lupin Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Lupin Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.9.5 Lupin Recent Developments/Updates

6.10 IL-YANG PHARM CO. LTD.

6.10.1 IL-YANG PHARM CO. LTD. Corporation Information

6.10.2 IL-YANG PHARM CO. LTD. Description and Business Overview

6.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.10.5 IL-YANG PHARM CO. LTD. Recent Developments/Updates

6.11 Million Health Pharmaceuticals

6.11.1 Million Health Pharmaceuticals Corporation Information

6.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Description and Business Overview

6.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.11.5 Million Health Pharmaceuticals Recent Developments/Updates

6.12 Celon Labs

6.12.1 Celon Labs Corporation Information

6.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Description and Business Overview

6.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Portfolio

6.12.5 Celon Labs Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Myeloid Leukemia Treatment Drugs Industry Chain Analysis

7.2 Chronic Myeloid Leukemia Treatment Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Myeloid Leukemia Treatment Drugs Production Mode & Process

7.4 Chronic Myeloid Leukemia Treatment Drugs Sales and Marketing

7.4.1 Chronic Myeloid Leukemia Treatment Drugs Sales Channels

7.4.2 Chronic Myeloid Leukemia Treatment Drugs Distributors

7.5 Chronic Myeloid Leukemia Treatment Drugs Customers

8 Chronic Myeloid Leukemia Treatment Drugs Market Dynamics

8.1 Chronic Myeloid Leukemia Treatment Drugs Industry Trends

8.2 Chronic Myeloid Leukemia Treatment Drugs Market Drivers

8.3 Chronic Myeloid Leukemia Treatment Drugs Market Challenges

8.4 Chronic Myeloid Leukemia Treatment Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical Industries Ltd

F Hoffmann La Roche Ltd

Novartis

Bristol Myers Squibb Company

Pfizer Inc

Takeda Pharmaceutical Company Limited

Innovent Biologics, Inc.

Viatris Inc. (Mylan N.V.)

Lupin Ltd

IL-YANG PHARM CO. LTD.

Million Health Pharmaceuticals

Celon Labs

List of Tables

Table 1. Global Chronic Myeloid Leukemia Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Chronic Myeloid Leukemia Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Chronic Myeloid Leukemia Treatment Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Chronic Myeloid Leukemia Treatment Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Chronic Myeloid Leukemia Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Chronic Myeloid Leukemia Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Myeloid Leukemia Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Chronic Myeloid Leukemia Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Chronic Myeloid Leukemia Treatment Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Chronic Myeloid Leukemia Treatment Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Chronic Myeloid Leukemia Treatment Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Chronic Myeloid Leukemia Treatment Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Teva Pharmaceutical Industries Ltd Corporation Information

Table 71. Teva Pharmaceutical Industries Ltd Description and Business Overview

Table 72. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product

Table 74. Teva Pharmaceutical Industries Ltd Recent Developments/Updates

Table 75. F. Hoffmann-La Roche Ltd. Corporation Information

Table 76. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 77. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product

Table 79. F. Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 80. Novartis AG Corporation Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. Bristol-Myers Squibb Company Corporation Information

Table 86. Bristol-Myers Squibb Company Description and Business Overview

Table 87. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product

Table 89. Bristol-Myers Squibb Company Recent Developments/Updates

Table 90. Pfizer Inc. Corporation Information

Table 91. Pfizer Inc. Description and Business Overview

Table 92. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product

Table 94. Pfizer Inc. Recent Developments/Updates

Table 95. Takeda Pharmaceutical Company Limited Corporation Information

Table 96. Takeda Pharmaceutical Company Limited Description and Business Overview

Table 97. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product

Table 99. Takeda Pharmaceutical Company Limited Recent Developments/Updates

Table 100. Innovent Biologics, Inc. Corporation Information

Table 101. Innovent Biologics, Inc. Description and Business Overview

Table 102. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product

Table 104. Innovent Biologics, Inc. Recent Developments/Updates

Table 105. Viatris Inc. (Mylan N.V.) Corporation Information

Table 106. Viatris Inc. (Mylan N.V.) Description and Business Overview

Table 107. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product

Table 109. Viatris Inc. (Mylan N.V.) Recent Developments/Updates

Table 110. Lupin Corporation Information

Table 111. Lupin Description and Business Overview

Table 112. Lupin Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Lupin Chronic Myeloid Leukemia Treatment Drugs Product

Table 114. Lupin Recent Developments/Updates

Table 115. IL-YANG PHARM CO. LTD. Corporation Information

Table 116. IL-YANG PHARM CO. LTD. Description and Business Overview

Table 117. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product

Table 119. IL-YANG PHARM CO. LTD. Recent Developments/Updates

Table 120. Million Health Pharmaceuticals Corporation Information

Table 121. Million Health Pharmaceuticals Description and Business Overview

Table 122. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product

Table 124. Million Health Pharmaceuticals Recent Developments/Updates

Table 125. Celon Labs Corporation Information

Table 126. Celon Labs Description and Business Overview

Table 127. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product

Table 129. Celon Labs Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Chronic Myeloid Leukemia Treatment Drugs Distributors List

Table 133. Chronic Myeloid Leukemia Treatment Drugs Customers List

Table 134. Chronic Myeloid Leukemia Treatment Drugs Market Trends

Table 135. Chronic Myeloid Leukemia Treatment Drugs Market Drivers

Table 136. Chronic Myeloid Leukemia Treatment Drugs Market Challenges

Table 137. Chronic Myeloid Leukemia Treatment Drugs Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Chronic Myeloid Leukemia Treatment Drugs

Figure 2. Global Chronic Myeloid Leukemia Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Type in 2023 & 2030

Figure 4. Tablet Product Picture

Figure 5. Solution Product Picture

Figure 6. Capsule Product Picture

Figure 7. Global Chronic Myeloid Leukemia Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application in 2023 & 2030

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Chronic Myeloid Leukemia Treatment Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Chronic Myeloid Leukemia Treatment Drugs Sales (2019-2030) & (K Units)

Figure 15. Global Chronic Myeloid Leukemia Treatment Drugs Average Price (US$/Unit) & (2019-2030)

Figure 16. Chronic Myeloid Leukemia Treatment Drugs Report Years Considered

Figure 17. Chronic Myeloid Leukemia Treatment Drugs Sales Share by Manufacturers in 2023

Figure 18. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Chronic Myeloid Leukemia Treatment Drugs Players: Market Share by Revenue in 2023

Figure 20. Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country (2019-2030)

Figure 23. North America Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Country (2019-2030)

Figure 24. United States Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country (2019-2030)

Figure 27. Europe Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Region (2019-2030)

Figure 35. China Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country (2019-2030)

Figure 45. Latin America Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Chronic Myeloid Leukemia Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2030)

Figure 55. Global Revenue Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2030)

Figure 56. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Application (2019-2030)

Figure 58. Global Revenue Market Share of Chronic Myeloid Leukemia Treatment Drugs by Application (2019-2030)

Figure 59. Global Chronic Myeloid Leukemia Treatment Drugs Price (US$/Unit) by Application (2019-2030)

Figure 60. Chronic Myeloid Leukemia Treatment Drugs Value Chain

Figure 61. Chronic Myeloid Leukemia Treatment Drugs Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Polycythemia Vera Treatment Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0O15761

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Exosome Medical Technology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U12944

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Chronic Myeloid Leukemia Treatment Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9Z15668

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Lymphoma Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10S14319

Mon Jun 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions